|
1
|
Brainard GC, Hanifin JP, Greeson JM, Byrne
B, Glickman G, Gerner E and Rollag MD: Action spectrum for
melatonin regulation in humans: Evidence for a novel circadian
photoreceptor. J Neurosci. 21:6405–6412. 2001.PubMed/NCBI
|
|
2
|
Lerner AB, Case JD and Takahashi Y:
Isolation of melatonin and 5-methoxyindole-3-acetic acid from
bovine pineal glands. J Biol Chem. 235:1992–1997. 1960.PubMed/NCBI
|
|
3
|
Stehle JH, von Gall C and Korf HW:
Melatonin: A clock-output, a clock-input. J Neuroendocrinol.
15:383–389. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Hastings MH, Reddy AB and Maywood ES: A
clockwork web: Circadian timing in brain and periphery, in health
and disease. Nat Rev Neurosci. 4:649–661. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Slominski RM, Reiter RJ,
Schlabritz-Loutsevitch N, Ostrom RS and Slominski AT: Melatonin
membrane receptors in peripheral tissues: Distribution and
functions. Mol Cell Endocrinol. 351:152–166. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Claustrat B, Brun J and Chazot G: The
basic physiology and pathophysiology of melatonin. Sleep Med Rev.
9:11–24. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Dubocovich ML, Delagrange P, Krause DN,
Sugden D, Cardinali DP and Olcese J: International union of basic
and clinical pharmacology. LXXV. Nomenclature, classification, and
pharmacology of G protein-coupled melatonin receptors. Pharmacol
Rev. 62:343–380. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Acuña-Castroviejo D, Escames G, Venegas C,
Díaz-Casado ME, Lima-Cabello E, López LC, Rosales-Corral S, Tan DX
and Reiter RJ: Extrapineal melatonin: Sources, regulation, and
potential functions. Cell Mol Life Sci. 71:2997–3025. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Burstein HJ, Polyak K, Wong JS, Lester SC
and Kaelin CM: Ductal carcinoma in situ of the breast. N Engl J
Med. 350:1430–1441. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Pagani O, Senkus E, Wood W, Colleoni M,
Cufer T, Kyriakides S, Costa A, Winer EP and Cardoso F; ESO-MBC
Task Force, : International guidelines for management of metastatic
breast cancer: Can metastatic breast cancer be cured? J Natl Cancer
Inst. 102:456–463. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Virnig BA, Tuttle TM, Shamliyan T and Kane
RL: Ductal carcinoma in situ of the breast: A systematic review of
incidence, treatment, and outcomes. J Natl Cancer Inst.
102:170–178. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Rabstein S, Harth V, Justenhoven C, Pesch
B, Plöttner S, Heinze E, Lotz A, Baisch C, Schiffermann M, Brauch
H, et al: Polymorphisms in circadian genes, night work and breast
cancer: Results from the GENICA study. Chronobiol Int.
31:1115–1122. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Van Dycke KC, Rodenburg W, van Oostrom CT,
van Kerkhof LW, Pennings JL, Roenneberg T, van Steeg H and van der
Horst GT: Chronically alternating light cycles increase breast
cancer risk in mice. Curr Biol. 25:1932–1937. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Basler M, Jetter A, Fink D, Seifert B,
Kullak-Ublick GA and Trojan A: Urinary excretion of melatonin and
association with breast cancer: Meta-analysis and review of the
literature. Breast Care (Basel). 9:182–187. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Schernhammer ES and Hankinson SE: Urinary
melatonin levels and breast cancer risk. J Natl Cancer Inst.
97:1084–1087. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Innominato PF, Lim AS, Palesh O, Clemons
M, Trudeau M, Eisen A, Wang C, Kiss A, Pritchard KI and Bjarnason
GA: The effect of melatonin on sleep and quality of life in
patients with advanced breast cancer. Support Care Cancer.
24:1097–1105. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Hill SM, Belancio VP, Dauchy RT, Xiang S,
Brimer S, Mao L, Hauch A, Lundberg PW, Summers W, Yuan L, et al:
Melatonin: An inhibitor of breast cancer. Endocr Relat Cancer.
22:R183–R204. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Kumar P and Aggarwal R: An overview of
triple-negative breast cancer. Arch Gynecol Obstet. 293:247–269.
2016. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Oprea-Ilies G, Haus E, Sackett-Lundeen L,
Liu Y, McLendon L, Busch R, Adams A and Cohen C: Expression of
melatonin receptors in triple negative breast cancer (TNBC) in
African American and Caucasian women: Relation to survival. Breast
Cancer Res Treat. 137:677–687. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Cho SG, Li D, Tan K, Siwko SK and Liu M:
KiSS1 and its G-protein-coupled receptor GPR54 in cancer
development and metastasis. Cancer Metastasis Rev. 31:585–591.
2012. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Tena-Sempere M: Roles of kisspeptins in
the control of hypothalamic-gonadotropic function: Focus on sexual
differentiation and puberty onset. Endocr Dev. 17:52–62. 2010.
View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Papaoiconomou E, Lymperi M, Petraki C,
Philippou A, Msaouel P, Michalopoulou F, Kafiri G, Vassilakos G,
Zografos G and Koutsilieris M: Kiss-1/GPR54 protein expression in
breast cancer. Anticancer Res. 34:1401–1407. 2014.PubMed/NCBI
|
|
23
|
Marot D, Bieche I, Aumas C, Esselin S,
Bouquet C, Vacher S, Lazennec G, Perricaudet M, Kuttenn F, Lidereau
R and de Roux N: High tumoral levels of Kiss1 and G-protein-coupled
receptor 54 expression are correlated with poor prognosis of
estrogen receptor-positive breast tumors. Endocr Relat Cancer.
14:691–702. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Kostadima L, Pentheroudakis G and Pavlidis
N: The missing kiss of life: Transcriptional activity of the
metastasis suppressor gene KiSS1 in early breast cancer. Anticancer
Res. 27:2499–2504. 2007.PubMed/NCBI
|
|
25
|
Stark AM, Tongers K, Maass N, Mehdorn HM
and Held-Feindt J: Reduced metastasis-suppressor gene
mRNA-expression in breast cancer brain metastases. J Cancer Res
Clin Oncol. 131:191–198. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Revel FG, Saboureau M, Masson-Pévet M,
Pévet P, Mikkelsen JD and Simonneaux V: Kisspeptin mediates the
photoperiodic control of reproduction in hamsters. Curr Biol.
16:1730–1735. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Gingerich S, Wang X, Lee PK, Dhillon SS,
Chalmers JA, Koletar MM and Belsham DD: The generation of an array
of clonal, immortalized cell models from the rat hypothalamus:
Analysis of melatonin effects on kisspeptin and
gonadotropin-inhibitory hormone neurons. Neuroscience.
162:1134–1140. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Borin TF, Arbab AS, Gelaleti GB, Ferreira
LC, Moschetta MG, Jardim-Perassi BV, Iskander AS, Varma NR, Shankar
A, Coimbra VB, et al: Melatonin decreases breast cancer metastasis
by modulating Rho-associated kinase protein-1 expression. J Pineal
Res. 60:3–15. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Jardim-Perassi BV, Lourenco MR, Doho GM,
Grígolo IH, Gelaleti GB, Ferreira LC, Borin TF, Moschetta MG and de
Campos Zuccari DA Pires: Melatonin regulates angiogenic factors
under hypoxia in breast cancer cell lines. Anticancer Agents Med
Chem. 16:347–358. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Jardim-Perassi BV, Arbab AS, Ferreira LC,
Borin TF, Varma NR, Iskander AS, Shankar A, Ali MM and de Campos
Zuccari DA: Effect of melatonin on tumor growth and angiogenesis in
xenograft model of breast cancer. PLoS One. 9:e853112014.
View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Mao L, Yuan L, Slakey LM, Jones FE, Burow
ME and Hill SM: Inhibition of breast cancer cell invasion by
melatonin is mediated through regulation of the p38
mitogen-activated protein kinase signaling pathway. Breast Cancer
Res. 12:R1072010. View
Article : Google Scholar : PubMed/NCBI
|
|
32
|
Ortiz-López L, Morales-Mulia S,
Ramirez-Rodriguez G and Benitez-King G: ROCK-regulated cytoskeletal
dynamics participate in the inhibitory effect of melatonin on
cancer cell migration. J Pineal Res. 46:15–21. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Mao L, Yuan L, Xiang S, Zeringue SB,
Dauchy RT, Blask DE, Hauch A and Hill SM: Molecular deficiency
(ies) in MT1 melatonin signaling pathway underlies the
melatonin-unresponsive phenotype in MDA-MB-231 human breast cancer
cells. J Pineal Res. 56:246–253. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Bresnick EH, Lee HY, Fujiwara T, Johnson
KD and Keles S: GATA switches as developmental drivers. J Biol
Chem. 285:31087–31093. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Morceau F, Schnekenburger M, Dicato M and
Diederich M: GATA-1: Friends, brothers, and coworkers. Ann NY Acad
Sci. 1030:537–554. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Zheng R and Blobel GA: GATA transcription
factors and cancer. Genes Cancer. 1:1178–1188. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Naylor MJ and Ormandy CJ: Gata-3 and
mammary cell fate. Breast Cancer Res. 9:3022007. View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Kouros-Mehr H, Kim JW, Bechis SK and Werb
Z: GATA-3 and the regulation of the mammary luminal cell fate. Curr
Opin Cell Biol. 20:164–170. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Oh DS, Troester MA, Usary J, Hu Z, He X,
Fan C, Wu J, Carey LA and Perou CM: Estrogen-regulated genes
predict survival in hormone receptor-positive breast cancers. J
Clin Oncol. 24:1656–1664. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
40
|
Engelsen IB, Stefansson IM, Akslen LA and
Salvesen HB: GATA3 expression in estrogen receptor alpha-negative
endometrial carcinomas identifies aggressive tumors with high
proliferation and poor patient survival. Am J Obstet Gynecol.
199:543.e1–e7. 2008. View Article : Google Scholar
|
|
41
|
Demir H, Turna H, Can G and Ilvan S:
Clinicopathologic and prognostic evaluation of invasive breast
carcinoma molecular subtypes and GATA3 expression. J BUON.
15:774–782. 2010.PubMed/NCBI
|
|
42
|
Cimino-Mathews A, Subhawong AP, Illei PB,
Sharma R, Halushka MK, Vang R, Fetting JH, Park BH and Argani P:
GATA3 expression in breast carcinoma: Utility in triple-negative,
sarcomatoid, and metastatic carcinomas. Hum Pathol. 44:1341–1349.
2013. View Article : Google Scholar : PubMed/NCBI
|
|
43
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(−Delta Delta C(T) method. Methods. 25:402–408. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
44
|
Pfaffl MW: A new mathematical model for
relative quantification in real-time RT-PCR. Nucleic Acids Res.
29:e452001. View Article : Google Scholar : PubMed/NCBI
|
|
45
|
Nocillado JN, Mechaly AS and Elizur A: In
silico analysis of the regulatory region of the Yellowtail Kingfish
and Zebrafish Kiss and Kiss receptor genes. Fish Physiol Biochem.
39:59–63. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
46
|
Borin TF, Arbab AS, Gelaleti GB, Ferreira
LC, Moschetta MG, Jardim-Perassi BV, Iskander AS, Varma NR, Shankar
A, Coimbra VB, et al: Melatonin decreases breast cancer metastasis
by modulating Rho-associated kinase protein-1 expression. J Pineal
Res. 60:3–15. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
47
|
Papantoniou K, Pozo OJ, Espinosa A, Marcos
J, Castaño-Vinyals G, Basagaña X, Pagès E Juanola, Mirabent J,
Martín J, Faro P Such, et al: Increased and mistimed sex hormone
production in night shift workers. Cancer Epidemiol Biomarkers
Prev. 24:854–863. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
48
|
Stevens RG, Brainard GC, Blask DE, Lockley
SW and Motta ME: Breast cancer and circadian disruption from
electric lighting in the modern world. CA Cancer J Clin.
64:207–218. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
49
|
Kim NN, Choi YU, Park HS and Choi CY:
Kisspeptin regulates the somatic growth-related factors of the
cinnamon clownfish Amphiprion melanopus. Comp Biochem Physiol A Mol
Integr Physiol. 179:17–24. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
50
|
Alvarado MV, Carrillo M and Felip A:
Melatonin-induced changes in kiss/gnrh gene expression patterns in
the brain of male sea bass during spermatogenesis. Comp Biochem
Physiol A Mol Integr Physiol. 185:69–79. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
51
|
Zhao GY, Li ZY, Zou HL, Hu ZL, Song NN,
Zheng MH, Su CJ and Ding YQ: Expression of the transcription factor
GATA3 in the postnatal mouse central nervous system. Neurosci Res.
61:420–428. 2008. View Article : Google Scholar : PubMed/NCBI
|
